Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-World Iptacopan Treatment in Paroxysmal Nocturnal Hemoglobinuria in China
ChiCTR2500109568Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Iptacopan in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by West China Hospital of Sichuan University. Primary endpoint: hemoglobin. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
Iptacopan
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on ChiCTR2500109568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109568.